Fitz - Pyrimidine anti-metabolites Flashcards
pyrimidine anti-metabolite drugs that inhibit DNA synthesis
- 5 flurouracil
- capecitabine
- cytarabine (Ara-C)
- gemcitabine
active metabolites of 5-FU
FdUMP, FdUTP, FUTP
FdUMB inhibits
thymidylate synthase
FdUTP and FUTP action
damage DNA and RNA, respectively
oral pro-drug of 5FU
capecitabine
MOA: gemcitabine
inhibition of DNA synthesis
MOA: cytarabine (ara-C)
inhibition of DNA synthesis via competetive inhibition of DNA polymerase
use of 5FU
solid tumors - colorectal and other GI, breast, ovarian cancers; topical - basal cell ca
use of capecitabine
colorectal cancer, met breast cancer (res to paclitaxel/anthracycline)
use of gemcitabine
pancreatic cancer
use of ara-C
AML (w/ 6-thioguanine, daunorubicin)
DLT: 5FU
- severe GI intolerance
- mucositis
- myelosuppresion
DLT: capecitabine
- severe GI intolerance
- mucositis
- myelosuppresion
- hand-foot syndrome ***
DLT: gemcitabine
myelosuppression - neutropenia
DLT: ara-C
severe myelosuppresion - granulocytopenia
site of activation of 5FU
inside tumor cells
5FU acts in what phase of the cell cycle
S phase
5FU>5FUdR
thymidine phosphorylase
5FUdR>5FdUMP
thymidine kinase
5FUdR inhibition of thymidylate synthase needs
folic acid
5FUdR inhibition of thymidylate synthase causes an increase in
dUTP
incorporated into RNA to cause damage
FUTP
type of tumor more resistant to 5FU
those with higher levels of thymidylate synthase, ie ass’d with TS gene amp
5FU is cleared by
liver